Evidence map›Paper›PMID 31405972›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2019

Upregulation of reduced folate carrier by vitamin D enhances brain folate uptake in mice lacking folate receptor alpha.

Camille Alam, Susanne Aufreiter, Constantine J Georgiou, Md Tozammel Hoque, Richard H Finnell, Deborah L O'Connor, I David Goldman, Reina Bendayan

Erratum issuedAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
  4. Review
  5. Frontiers in endocrinology · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Mitochondrial One-Carbon Metabolism and Alzheimer's Disease.International journal of molecular sciences · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Camille AlamDepartment of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON M5S 3M2, Canada.
Susanne AufreiterTranslational Medicine Program, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.
Constantine J GeorgiouDepartment of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON M5S 3M2, Canada.
Md Tozammel HoqueDepartment of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON M5S 3M2, Canada.
Richard H FinnellDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030.
Deborah L O'ConnorTranslational Medicine Program, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.
I David GoldmanDepartment of Medicine, Albert Einstein College of Medicine, Bronx, NY 10461.
Reina BendayanDepartment of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON M5S 3M2, Canada; r.bendayan@utoronto.ca.

Funding

Proton-coupled folate/antifolate transportR01CA082621 · NCI · YESHIVA UNIVERSITY · PI GOLDMAN, ISRAEL DAVID · 1999 to 2017
$9.0M
INTERVENTION STRATEGIES FOR NON-FOLATE RESPONSIVE NEURAL TUBE DEFECTSR01HD083809 · NICHD · UNIVERSITY OF TEXAS AT AUSTIN · PI FINNELL, RICHARD H. · 2016 to 2024
$5.1M
Folic Acid, Parental Mutation Rates and the Risk for Neural Tube DefectsR01HD081216 · NICHD · UNIVERSITY OF TEXAS AT AUSTIN · PI FINNELL, RICHARD H., LEI, YUNPING · 2015 to 2019
$2.5M
NCI NIH HHS R01 CA082621NICHD NIH HHS R01 HD081216NICHD NIH HHS R01 HD083809
6 · The paper itself

Abstract

Folates are critical for central nervous system function. Folate transport is mediated by 3 major pathways, reduced folate carrier (RFC), proton-coupled folate transporter (PCFT), and folate receptor alpha (FRα/Folr1), known to be regulated by ligand-activated nuclear receptors. Cerebral folate delivery primarily occurs at the choroid plexus through FRα and PCFT; inactivation of these transport systems can result in very low folate levels in the cerebrospinal fluid causing childhood neurodegenerative disorders. These disorders have devastating effects in young children, and current therapeutic approaches are not sufficiently effective. Our group has previously reported in vitro that functional expression of RFC at the blood-brain barrier (BBB) and its upregulation by the vitamin D nuclear receptor (VDR) could provide an alternative route for brain folate uptake. In this study, we further demonstrated in vivo, using Folr1 knockout (KO) mice, that loss of FRα led to a substantial decrease of folate delivery to the brain and that pretreatment of Folr1 KO mice with the VDR activating ligand, calcitriol (1,25-dihydroxyvitamin D

Indexed as

AnimalsBiological TransportBiomarkersBlood-Brain BarrierBrainChromatography, LiquidFemaleFolate Receptor 1Folic AcidGene ExpressionImmunohistochemistryMiceMice, KnockoutReduced Folate Carrier ProteinTandem Mass SpectrometryVitamin DBiomarkersFolate Receptor 1Folic AcidFolr1 protein, mouseReduced Folate Carrier ProteinVitamin Dblood–brain barrierbrain folate transportvitamin D receptor

Identifiers

PMID31405972
PMCPMC6717308

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.